Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Department of Pharmacology has been judged best in the world for the second year in a row in the QS World Rankings, published today.

Pharmacology is one of eight subject areas at Oxford that top the World Rankings for 2020 - in increase from the five top place rankings in 2019. The University of Oxford secured the highest number of top place subject rankings for a UK institution for the second year running.

Jack Moran, QS Spokesperson, said: “It is a testament to the University of Oxford’s enduring quality that it has not just kept pace with the rate of improvement enjoyed by highly-ambitious, well-funded peers abroad – but has actually managed to continue raising the bar in many areas. A deeper delve into our dataset highlights the outstanding regard in which Oxford’s graduates are held, and the extraordinary impact of the academic inquiry taking place among the spires.”

Each of the subject rankings is compiled using four sources. The first two of these are QS’s global surveys of academics and employers (83,000 academics and 42,000 employers), which are used to assess institutions’ international reputation in each subject. The second two indicators assess research impact, based on research citations per paper and h-index in the relevant subject. These are sourced from Elsevier’s Scopus database, the world’s most comprehensive research citations database. 

Similar stories

International collaboration by Potter group uncovers vital element in regulation of Na⁺/K⁺- ATPase-α1

Department

An international collaboration of the Potter Group with Solomon Snyder’s Group in the USA and with Chinese and German colleagues has uncovered the myo-inositol polyphosphate pyrophosphate 5-InsP7 as a regulator of the Na⁺/K⁺- ATPase-α1

Professor Angela Russell receives 2021 Harrington UK Rare Disease Scholar Award

Department Russell Group

Angela Russell, Professor of Medicinal Chemistry in the Oxford Departments of Pharmacology and Chemistry, has been announced as one of the five recipients of the inaugural UK Rare Disease Scholar Award, presented by the Harrington Discovery Institute (HDI).

Professor Fran Platt appointed as new Head of Department of Pharmacology

Department

Professor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.

The Department mourns the loss of three greats in neuropharmacology

Department

This summer three of the world’s most distinguished neurochemists died; each was a member of the Department during their outstanding scientific careers.

Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer

Department

There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).

New Galione group paper explores the role for early Ca2+ signals in phagocytosis

Department

The Galione Lab has a paper published in The EMBO Journal showing that local Ca2+‐nanodomains formed by two‐pore channels (TPCs) on endo-lysosomes are shown to drive phagocytosis in macrophages. Moreover, different endo-lysosomal Ca2+ channels do different jobs at phagocytosis (extreme compartmentation).